OnabotulinumtoxinA 155 U in medication overuse headache: a two years prospective study

The efficacy and safety of OnabotulinumtoxinA 155-195 U (BOTOX(®)) in adults with chronic migraine (CM) were demonstrated in both the Phase III Research Evaluating Migraine Prophylaxis Therapy (PREEMPT) studies. However, data about its long-term efficacy and safety in clinical settings are scanty. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Negro, Andrea, Curto, Martina, Lionetto, Luana, Crialesi, Dorotea, Martelletti, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695480/
https://www.ncbi.nlm.nih.gov/pubmed/26753113
http://dx.doi.org/10.1186/s40064-015-1636-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695480/
https://www.ncbi.nlm.nih.gov/pubmed/26753113
http://dx.doi.org/10.1186/s40064-015-1636-9

Ejemplares similares